Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

BACKGROUND: Patients with coronary disease may have unknown diabetes or prediabetes. We evaluated 3‐year outcomes after percutaneous coronary intervention (PCI) with contemporary drug‐eluting stents (DES) in patients with silent diabetes, prediabetes, and normoglycemia. METHODS: All BIO‐RESORT trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Ploumen, Eline H., Buiten, Rosaly A., Kok, Marlies M., Doggen, Carine J.M., van Houwelingen, K. Gert, Stoel, Martin G., de Man, Frits H.A.F., Hartmann, Marc, Zocca, Paolo, Linssen, Gerard C.M., Doelman, Cees, Kant, Gert D., von Birgelen, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496069/
https://www.ncbi.nlm.nih.gov/pubmed/31625262
http://dx.doi.org/10.1002/ccd.28536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496069/
https://www.ncbi.nlm.nih.gov/pubmed/31625262
http://dx.doi.org/10.1002/ccd.28536

Ejemplares similares